GASCO’s Best of the 2021 San Antonio Breast Cancer Symposium® & GASCO Annual Meeting and Best of Oncology

Nothing to disclose

Nothing to disclose

Research Funding paid to Institution -Abbvie |Research Funding paid to institution -Acerta Pharma|Research Funding paid to institution -ADC Therapeutics |Research Funding paid to institution -AKESOBIO Australia |Research Funding paid to institution -Amgen|Research Funding paid to institution -Aravive|Research Funding paid to institution -ArQule|Research Funding and Consulting paid to institution -AstraZeneca|Research Funding paid to institution -AtlasMedx|Research Funding and Consulting paid to institution -Black Diamond|Research Funding and Consulting paid to institution -Boehringer Ingelheim|Research Funding paid to institution -Clovis|Research Funding paid to institution -Compugen|Research Funding paid to institution -Curis|Research Funding and Consulting paid to institution -CytomX|Research Funding and Consulting paid to institution -Daiichi Sankyo|Research Funding paid to institution -Dana Farber Cancer Institute|Research Funding and Consulting paid to institution -Deciphera|Research Funding paid to institution -eFFECTOR Therapeutics |Research Funding paid to institution -Ellipses Pharma|Research Funding paid to institution -EMD Serono|Research Funding paid to institution -Fochon|Research Funding paid to institution -FujiFilm|Research Funding paid to institution -G1 Therapeutics |Research Funding and Consulting paid to institution -H3 Biomedicine |Research Funding paid to institution -Harpoon|Research Funding paid to institution -Hutchinson MediPharma|Research Funding paid to institution -Immunogen|Research Funding paid to institution -Immunomedics|Research Funding paid to institution -Incyte|Research Funding paid to institution -InvestisBio|Research Funding paid to institution -Jacobio|Research Funding paid to institution -Karyopharm|Research Funding paid to institution -Leap Therapeutics |Research Funding and Consulting paid to institution -Eli Lilly and Company|Research Funding paid to institution -Lycera|Research Funding paid to institution -Mabspace Biosciences|Research Funding paid to institution -Macrogenics |Research Funding paid to institution -MedImmune|Research Funding and Consulting paid to institution -Merck and Company, Inc.|Research Funding and Consulting paid to institution -Mersana|Research Funding paid to institution -Merus|Research Funding paid to institution -Millennium Pharmaceuticals, Inc.|Research Funding paid to institution -Molecular Templates|Research Funding paid to institution -Myraid Genetic Laboratories |Research Funding and Novartis paid to institution -Novartis|Research Funding paid to institution -Nucana|Research Funding paid to institution -Olema|Research Funding paid to institution -OncoMed|Research Funding paid to institution -Onconova Therapeutics |Research Funding paid to institution -ORIC Pharmaceuticals|Research Funding paid to institution -Orinove|Research Funding and Consulting paid to institution -Pfizer, Inc.|Research Funding paid to institution -PharmaMar|Research Funding paid to institution -Pieris Pharmaceuticals |Research Funding paid to institution -Pionyr Immunotherapeutics |Research Funding paid to institution -Plexxikon|Research Funding paid to institution -Radius Health|Research Funding paid to institution -Regeneron|Research Funding paid to institution -Repertoire Immune Medicine |Research Funding paid to institution -Rgenix|Research Funding and Consulting paid to institution -F. Hoffmann La Roche Ltd.|Research Funding and Consulting paid to institution -Genentech, Inc.|Research Funding and Consulting paid to institution -SeaGen|Research Funding paid to institution -Sermonix Pharmaceuticals|Research Funding paid to institution -Shattuck Labs|Research Funding and Consulting paid to institution -Silverback |Research Funding paid to institution -StemCentRx|Research Funding paid to institution -Sutro|Research Funding paid to institution -Syndax|Research Funding paid to institution -Syros|Research Funding paid to institution -Taiho|Research Funding paid to institution -TapImmune|Research Funding paid to institution -Tesaro|Research Funding paid to institution -Treadwell Therapeutics |Research Funding paid to institution -Verastem|Research Funding paid to institution -Vincerx Pharma|Research Funding paid to institution -Zenith Epigenetics |Research Funding paid to institution -Zymeworks|Consulting paid to institution -Arcus|Consulting paid to institution -Dantari|Consulting paid to institution -Eisai, Inc.|Consulting paid to institution -iTeos|Consulting paid to institution -Janssen|Consulting paid to institution -Loxo|Consulting paid to institution -Puma Biotechnology |Consulting paid to institution -Relay Therapeutics |Research Funding and Consulting paid to institution -Arvinas

Salary-grail|Consulting Fee-Eli-Lilly, Pfizer, Novartis, Eisai, AstraZeneca, Daiichi Sankyo, Puma, 4D Pharma, Oncosec, Immunomedics, Merck, Seattle Genetics, and Cyclocel

Nothing to disclose

Nothing to disclose

Consulting Fee-Bristol-Myers Squibb|Consulting Fee-Genentech, Inc.|Consulting Fee-EMD Serono|Consulting Fee-Merck and Company, Inc.|Consulting Fee-Seattle Genetics/Astellas|Consulting Fee-Janssen|Consulting Fee-Eli Lilly and Company|Consulting Fee-Gilead|Consulting Fee-Scholar Rock|Consulting Fee-G1 Therapeutics|Consulting Fee-Loxo Oncology|Contracted Research-Sanofi-Aventis|Contracted Research-AstraZeneca|Contracted Research-Gilead|Contracted Research-QED|Contracted Research-Bristol-Myers Squibb|Data safety monitoring committee-Mereo|Editor-Elsevier Practice Update, Bladder Cancer Center